The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer
Open accessAbstract
BACKGROUND: The objective of this study was to identify predictive factors for pathologic complete response and tumor downstaging after preoperative chemoradiation for rectal cancer. METHODS: Between 1989 and 2004, 562 patients with nonmetastatic rectal adenocarcinoma received preoperative chemoradiation and underwent mesorectal excision. The median radiation dose was 45 Gray (Gy) (range, 19.8–58.6 Gy), 77% of patients received concurrent infusional 5‐fluorouracil, 20% of patients received concurrent capecitabine, and 3% of patients received other regimens. RESULTS: Nineteen percent of patients achieved a pathologic complete response (CR), whereas 20% of patients had only microscopic residual disease at surgery, and 61% of patients had macroscopic residual disease at surgery. Downstaging of the tumor stage occurred in 57% of patients. The results from a univariate analysis indicated that tumor circumferential extent >60% (P = .033) and pretreatment carcinoembryonic antigen (CEA) level >2.5 ng/mL (P = .015) were associated significantly with lower pathologic CR rates. The univariate analysis also indicated that tumor circumferential extent >60% (P = .001), pretreatment CEA level >2.5 ng/mL (P = .006), and distance from the anal verge >5 cm (P = .035) were associated significantly with lower downstaging rates. The results from a multivariate logistic regression analysis indicated that greater circumferential extent of tumor (odds ratio [OR], 0.43; P = .033) independently predicted a lower pathologic CR rate. The multivariate logistic regression analysis also indicated that greater circumferential extent of tumor (OR, 0.49; P = .020) and greater distance from the anal verge (OR, 0.46; P = .010) independently predicted a lower downstaging rate. CONCLUSIONS: Circumferential extent of tumor, CEA level, and distance from the anal verge predicted for the pathologic response to preoperative chemoradiation for patients with rectal cancer. Therefore, these factors may be used to predict outcomes for patients, to develop risk‐adapted treatment strategies, and to target patients who participate in trials of newer therapies. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Habr-Gama, A., Perez, R. O., Nadalin, W., Sabbaga, J., Ribeiro, U., Silva e Sousa, A. H., Campos, F. G., Kiss, D. R., & Gama-Rodrigues, J. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141194.27992.32 · Cited by 1,893
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
Rödel, C., Martus, P., Papadoupolos, T., Füzesi, L., Klimpfinger, M., Fietkau, R., Liersch, T., Hohenberger, W., Raab, R., Sauer, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1329 · Cited by 1,215
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., Briffaux, A., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.113 · Cited by 594
Ghadimi, B. M., Grade, M., Difilippantonio, M. J., Varma, S., Simon, R., Montagna, C., Füzesi, L., Langer, C., Becker, H., Liersch, T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.406 · Cited by 348
Local Excision of T2 and T3 Rectal Cancers After Downstaging Chemoradiation
Kim, C. J., Yeatman, T. J., Coppola, D., Trotti, A., Williams, B., Barthel, J. S., Dinwoodie, W., Karl, R. C., & Marcet, J. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00009 · Cited by 275
Janjan, N. A., Crane, C., Feig, B. W., Cleary, K., Dubrow, R., Curley, S., Vauthey, J.-N., Lynch, P., Ellis, L. M., Wolff, R., et al. (2001) · American Journal of Clinical Oncology: Cancer Clinical Trials · doi:10.1097/00000421-200104000-00001 · Cited by 271
Self-citationCascini, G. L., Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Marone, P., Aloj, L., Martinis, F. D., Comella, P., Parisi, V., et al. (2006) · PubMed · Cited by 215
Bonnen, M., Crane, C., Vauthey, J.-N., Skibber, J., Delclos, M. E., Rodriguez-Bigas, M., Hoff, P. M., Lin, E., Eng, C., Wong, A., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.062 · Cited by 189
Self-citationStipa, F., Chessin, D. B., Shia, J., Paty, P. B., Weiser, M., Temple, L. K. F., Minsky, B. D., Wong, W. D., & Guillem, J. G. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.053 · Cited by 173
Schell, S. R., Zlotecki, R. A., Mendenhall, W. M., Marsh, R., Vauthey, N. J., & Copeland, E. M. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(02)01128-6 · Cited by 149
Giralt, J., Heras, M. D. L., Cerezo, L., Eraso, A., Hermosilla, E., Velez, D., Luján, J., Espín, E., Rosselló-Urgell, J., Majó, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.021 · Cited by 144
Janjan, N. A., Abbruzzese, J. L., Pazdur, R., Khoo, V. S., Cleary, K. R., DuBrow, R. A., Ajani, J. A., Rich, T. A., Goswitz, M. S., Evetts, P. A., et al. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00054-7 · Cited by 141
Self-citationSerum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer
Park, Y.-A., Sohn, S. K., Seong, J., Baik, S. H., Lee, K.-Y., Kim, N. K., & Cho, C.-W. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20320 · Cited by 101
Long-term control of T2–T3 rectal adenocarcinoma with radiotherapy alone
Gérard, J., Chapet, O., Ramaioli, A., & Romestaing, P. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02879-1 · Cited by 97
Giralt, J., Eraso, A., Armengol, M., Rosselló-Urgell, J., Majó, J., Ares, C., Espín, E., Benavente, S., & de Torres, I. M. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03752-5 · Cited by 91
Wang, Y., Cummings, B., Catton, P. A., Dawson, L. A., Kim, J., Ringash, J. G., Wong, R. K. S., Yi, Q., & Brierley, J. D. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.09.001 · Cited by 82
Spindler, K. G., Nielsen, J. N., Lindebjerg, J., Brandslund, I., & Jakobsen, A. K. M. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.030 · Cited by 58
Smith, F. M., Reynolds, J. V., Kay, E. W., Crotty, P. L., Murphy, J. O., Hollywood, D. P., Gaffney, E. F., Stephens, R. B., & Kennedy, M. J. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.961 · Cited by 50
Gérard, J., Romestaing, P., Bonnetain, F., Conroy, T., Bouché, O., Desjardins, M. C., Untereiner, M., Leduc, B., François, É., & Bedenne, L. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.010 · Cited by 19
Preoperative and adjuvant treatment of localized rectal cancer
Das, P., & Crane, C. H. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0016-6 · Cited by 8
Self-citation
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Self-citationRectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Self-citationNeoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
Park, I. J., You, Y. N., Agarwal, A., Skibber, J. M., Rodriguez-Bigas, M. A., Eng, C., Feig, B. W., Das, P., Krishnan, S., Crane, C. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7901 · Cited by 485
Self-citationKalady, M. F., de Campos-Lobato, L. F., Stocchi, L., Geisler, D. P., Dietz, D., Lavery, I. C., & Fazio, V. W. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b91e63 · Cited by 386
Metadata
- Authors
- Das, P., Skibber, J. M., Rodriguez‐Bigas, M. A., Feig, B. W., Chang, G. J., Wolff, R. A., Eng, C., Krishnan, S., Janjan, N. A., & Crane, C. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-04-18
- Volume
- 109
- Issue
- 9
- Pages
- 1750-1755
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2040660199
- Cited by
- 332
- References
- 25
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.